Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The Sweden location entry in the study's locations list has been updated from Malmo to Malmö, correcting the city spelling in Skåne County. This preserves an accurate and searchable location for participants and records.
    Difference
    0.0%
    Check dated 2026-05-04T08:25:21.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new related publication (on CD8+ T cells in ankylosing spondylitis) is added to the study’s publications list. The site’s displayed release/version label is updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-27T07:51:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-20T04:58:39.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Added a new publication reference: 'Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis' (Rheumatol Ther. 2026). Updated revision to v3.5.0 (from v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-22T10:31:35.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T03:35:47.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page footer. No changes to study details, eligibility criteria, locations, or outcomes.
    Difference
    0.0%
    Check dated 2026-02-14T12:59:18.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.